April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

German biotech firm CureVac has taken Moderna to court in Delaware, claiming the American drugmaker’s blockbuster Spikevax ...

COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...

By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, ...

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot. Reading time 3 minutes The federal government’s crusade against ...

Many countries including Canada and the U.K. have backed mix-and-match strategies for the widely-used AstraZeneca-Oxford vaccine, which is not authorized in the United States but is based on similar ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

The U.S. Food and Drug Administration (FDA) has refused to consider Moderna’s application for a new flu vaccine, which utilizes Nobel Prize-winning mRNA technology, the company announced on Tuesday.

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.

Republican Wisconsin Sen. Ron Johnson held a hearing probing Biden officials over the handling of COVID-19 vaccine safety ...

A new effort to prepare for future avian influenza outbreaks is moving forward despite a major funding setback.